Search for: "THE OFFICE OF MEDICAID POLICY AND PLANNING"
Results 261 - 280
of 955
Sort by Relevance
|
Sort by Date
7 May 2020, 9:05 pm
Food and Drug Administration (FDA) recently announced a new policy that calls for heightened standards for laboratories and commercial manufacturers to increase the development and availability of COVID-19 antibody tests. [read post]
6 May 2020, 12:12 pm
Approved plans include an array of bare-bones insurance policies that provide minimal benefits and are thus incompatible with the comprehensive coverage in the ACA. [read post]
5 May 2020, 11:50 am
Planned Parenthood South Atlantic 19-1186Issues: (1) Whether Medicaid recipients have a private right of action under 42 U.S.C. [read post]
28 Apr 2020, 9:26 am
Because of such legislation, a shift in policy by some healthcare service businesses has led to an increase in volume coming in through managed Medicaid but at lower than expected payor rates. [read post]
17 Apr 2020, 7:00 am
The deed works like a beneficiary designation on a retirement plan or an insurance policy. [read post]
16 Apr 2020, 9:05 pm
Benatar called on state Medicaid programs to improve reimbursement rates for midwifery care and birth center facility payments, expand Medicaid-managed care plans to include freestanding birth centers within their networks, and immediately expand benefits to include coverage to midwives who attend home births, particularly in states that do not cover home births. [read post]
10 Apr 2020, 2:03 am
It depends on the law that created the particular office of the IG. [read post]
8 Apr 2020, 12:36 pm
Wade (1973) (citing Jacobson); Planned Parenthood v. [read post]
2 Apr 2020, 11:28 am
Texas: On April 1, Texas released Commissioner’s Bulletin # B-0016-20, which is directed to issuers of health plans that are not required to comply with the Affordable Care Act (alternative health plans). [read post]
2 Apr 2020, 10:13 am
Citizenship and Immigration Services office closures during this crisis. [read post]
25 Mar 2020, 10:00 am
New Targeted Plan for Health Facility Inspections: A. [read post]
24 Mar 2020, 10:15 am
Sources: National Conference of State Legislatures; National Association of State Budget Officers; state legislative websites and news articles. [read post]
23 Mar 2020, 1:28 pm
Recent Developments in Personal Care and Other Home and Community-Based Services in Medicaid and Medicare I. [read post]
19 Mar 2020, 9:48 am
Plans approved by the Secretary shall provide for supplemental allotments to households receiving benefits under such Act, and issuances to households not already receiving benefits. [read post]
16 Mar 2020, 1:32 pm
Medicare Advantage Plans were given the authority to expand their telehealth coverage through enhanced benefit packages last year, but coverage still varies from plan to plan. [read post]
14 Mar 2020, 5:18 am
House Speaker Nancy Pelosi on Friday announced the deal with the Trump administration for an aid package from Congress that would provide free tests even for the uninsured, enhanced unemployment benefits by boosting food stamps, and federal funds for Medicaid. [read post]
13 Mar 2020, 12:10 pm
Issued by two different agencies within HHS – the Office of the National Coordinator for Health Information Technology (ONC) and the Centers for Medicare and Medicaid Services (CMS) – the rules implement the interoperability and patient access provisions of the bipartisan 21st Century Cures Act. [read post]
11 Mar 2020, 2:07 pm
The agreement only technically binds Medicare, Medicaid and other government programs and private insurers participating in the meeting. [read post]
11 Mar 2020, 4:20 am
The two rules, issued by the HHS Office of the National Coordinator for Health Information Technology (ONC) and Centers for Medicare & Medicaid Services (CMS), implement interoperability and patient access provisions of the 21st Century Cures Act (Cures Act) and support the MyHealthEData initiative, designed to allow patients to access their health claims information electronically through the application of their choosing. [read post]
9 Mar 2020, 1:21 pm
FDA Draft Guidance for Industry: Promotional Labeling and Advertising Considerations for Prescription Biological Reference and Biosimilar Products Questions and Answers Catherine Gray, Staff Director, Office of Prescription Drug Promotion, CDER, FDAElizabeth Pepinsky, Health Science Policy Analyst, Office of Prescription Drug Promotion, CDER, FDA: Draft guidance issued by OPDP in consultation w/other groups focusing on biosimilars. [read post]
